40 million would lose abortion access if court blocks pill, study shows 163% more women would lose access to abortion care if the FDA's approval of mifepristone is revoked. Axios · Feb 10, 2023
Dominic Raab calls for 'zero bullying' despite claims he drove officials to breakdowns Deputy Prime Minister Dominic Raab said he is 'confident' he has 'behaved professionally at all times' after civil servants who worked for him warned they had lost weight, suffered breakdowns or even felt suicidal Daily Mirror · Feb 10, 2023
Stop speaking publicly about bullying inquiry, union chief tells Raab The Deputy Prime Minister has said that the allegations against him published in the media were ‘mostly incorrect’. The Independent UK · Feb 10, 2023
The ‘rogue’ Trump-appointed judge with abortion pill’s future in his hands Judge Matthew Kacsmaryk has amassed a litany of contentious rulings in less than four years The Guardian - US · Feb 10, 2023
Chicken farmers say their eggs could help reduce prices Chicken producers want to do their part to bring down current soaring egg prices The Independent UK · Feb 9, 2023
5 Top Stocks to Buy for 2023 The stock market witnessed a solid start this year amid improving investors’ optimism. Moreover, experts see increased chances of a soft landing. So, fundamentally strong stocks Merck (MRK), Novartis (NVS), Sysco (SYY), Progress Software (PRGS), and LSI Industries (LYTS) could be solid buys now. These stocks pay consistent dividends. Read… StockNews.com · Feb 9, 2023
Medication abortion could get harder to obtain – or easier: There's a new wave of post-Dobbs lawsuits on abortion pills Medication abortion now accounts for more than half of all abortions in the United States. The Conversation · Feb 9, 2023
CBD is not a cure-all – here's what science says about its real health benefits Over the last five years, an often forgotten piece of U.S. federal legislation – the Agriculture Improvement Act of 2018, also known as the 2018 Farm Bill – has ushered in an explosion of interest in the medical potential of cannabis-derived cannabidiol, or CBD. The Conversation · Feb 9, 2023
Q&A: Why Bernie Sanders says his ‘Medicare for All’ dream must wait After railing at the injustices of U.S. health care for decades, Sen. Bernie Sanders in January became the new chairman of the Senate Health, Education, Labor & Pensions Committee. The job gives the health care industry’s biggest Washington nemesis an unprecedented opportunity to shape health care reform in Congress. But… Tribune News Service · Feb 9, 2023
Remembering the Great Pizza Funeral of 1973 Fifty years ago, dozens of people gathered in Ossineke, Michigan, for one of the strangest funerals in American history Reason · Feb 9, 2023
Trump judge’s ruling could ban abortion pill across the US Far-right groups have asked to reverse the FDA’s approval of mifepristone, which has been on the market for decades The Guardian - US · Feb 9, 2023
Robin Abcarian: Bad news: A Texas judge holds the future of medication abortion in his very conservative hands Could a federal judge really declare that an abortion drug used safely by millions of American women over more than two decades did not receive proper vetting and force it off the market? Los Angeles Times · Feb 9, 2023
Texas scientists create fentanyl vaccine to combat opioid epidemic To combat the fentanyl epidemic in the United States, researchers at the University of Houston have created a fentanyl vaccine that could help prevent overdoses. They aim to test the vaccine in a human trial within the next year. Tribune News Service · Feb 9, 2023
Biden's Anti-Vaping Policies Undermine Cancer Moonshot To reduce cancer deaths, Biden should stop restricting safer nicotine alternatives. Reason · Feb 8, 2023
Fortune · Feb 8, 2023 One of Biden’s top COVID advisors believes vaccine critics ‘quietly’ got jabbed on the side The White House's former Chief Science Officer for the COVID-19 Response Team wants to work with with vaccine skeptics to solve the COVID problem.
Tribune News Service · Feb 8, 2023 Matthew Yglesias: Trump isn’t touting his biggest success One sunny spring morning in May 2020, President Donald Trump stood in the White House Rose Garden and announced what would turn out to be his administration’s most striking success: Operation Warp Speed, which combined an influx of money with some trimming of bureaucracy to generate safe and effective vaccines…
Salon · Feb 7, 2023 A technicality could withhold RSV shots A glitch in a law may make it difficult for children from low-income families to get the new RSV vaccine
Axios · Feb 7, 2023 Immunocompromised worry they're getting left behind again The immunocompromised have largely been an afterthought throughout the pandemic, patient advocacy groups say.
Bangkok Post · Feb 7, 2023 FDA defends vaccine shelf-life extensions The Food and Drug Administration has said it was following the latest approved safety information when it extended the shelf life of some batches of Pfizer Covid-19 vaccine to 15 months from nine.
StockNews.com · Feb 6, 2023 The Most Active Stocks to Buy on Wall Street This Week Amid concerns that an estimate-beating labor market tightness may embolden the Fed to keep pushing interest rates upward, fundamentally strong stocks Pfizer (PFE), Verizon (VZ), and AT&T (T) have deservedly found takers on Wall Street. Read on….
The Texas Tribune · Feb 5, 2023 Texas lawsuit that seeks to ban abortion drug nationwide sparks fear among advocates A decision on the lawsuit could come as early as this week.
The Independent UK · Feb 4, 2023 Why a new Alzheimer's drug is having a slow US debut The first drug to show that it slows Alzheimer’s is on sale, but treatment for most patients is still several months away
Fortune · Feb 4, 2023 Cancer vaccines are already a reality—but your doctor might not tell you about them unless you ask “Patients need to advocate for themselves."
StockNews.com · Feb 3, 2023 3 Stocks to Buy if You're Building a Portfolio From Scratch Shares of Pfizer (PFE), Centene (CNC), and Kellogg (K) could provide a solid foundation to new portfolios for sustained wealth creation, given the fundamental strength, consistent profitability, and resilient demand of these companies. Continue reading….
Reuters · Feb 3, 2023 U.S. FDA says India-made eye drop linked to some infections, blindness and one death The U.S. Food and Drug Administration (FDA) has warned against using an eye drop made in India that has been linked to the outbreak of a drug-resistant bacteria leading to adverse events in at least 55 patients in the United States including infections, blindness and one death.